CLINICAL_TRIALS
trial_result
· 2016-05-04
Clinical Trial Update: Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer [Phase 3]
Summary
Phase 3 trial evaluating selenium for preventing tumor growth in patients with previously resected stage I non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-05-04